Skip to main content

Research Repository

Advanced Search

Combinations of bleeding and ischemic risk and their association with clinical outcomes in acute coronary syndrome.

Mamas; Rashid



Acute coronary syndromes (ACS) are an important cause of morbidity and mortality worldwide. Current guidelines recommend early management with potent antiplatelet agents and an early invasive coronary intervention strategy for both non-ST elevation myocardial infarction (NSTEMI) and ST-elevation myocardial infarction (STEMI). The mainstay of pharmacologic treatment for ACS is the use of potent antithrombotic therapy to minimize the risk for further ischemic events, which comes at an expense of an increased risk of bleeding complications that are associated with high rates of morbidity and mortality.

Acceptance Date May 15, 2019
Publication Date Sep 1, 2019
Journal International Journal of Cardiology
Print ISSN 0167-5273
Publisher Elsevier
Pages 7-14
Keywords Grce, Crusade, risk scores, outcomes, treatment
Publisher URL